Edward M. Rudnic

This profile gathers the share dealings of Edward M. Rudnic in Advancis Pharmaceutical Corp. In total, 135 filings cover trades dated from 16 February 2006 to 26 November 2007.

On the market, this insider has only sold: 133 sales, €593k in total. The rest of the record consists of 2 option exercises. In 2007 alone, the filings show no purchases and 104 sales.

Most recently, on 26 November 2007, the filings show an open-market sale worth €1,061 in Advancis Pharmaceutical Corp. The median gap between a trade and its publication by SEC (Form 4) is 1 day. For comparison, the SEC allows two business days to file a Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.